Corteria Pharmaceuticals

Home page - Corteria

Founded 2021 · $84.2M raised

Founded
2021
Business Model
B2B
Total Funding
$84.2M
Last Round
$71.0M Series ASep 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Corteria Pharmaceuticals is a privately held company founded in 2021 to develop first-in-class drugs for indications of high unmet medical need, including worsening and acute decompensated heart failure, right heart failure, sarcopenia, and obesity with complications. The company uses innovative patient stratification and target selection based on human evidence and disease biology so treatments reach the patients most likely to benefit. Its pipeline includes COR-1167, a CRF2 peptide agonist entering Phase 2 for worsening heart failure, and COR-1389, in Phase 1 for obesity and right heart failure.

Summary

Corteria Pharmaceuticals is a Biotech company, founded in 2021. It has raised $84.2M in total across 2 rounds, most recently a $71.0M Series A round in Sep 2023. Investors include OrbiMed, Jeito Capital and Kurma Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ASep 2023
$71.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Corteria Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/corteria-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/corteria-pharmaceuticals" alt="Corteria Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>